Cost-utility analysis of eptinezumab for migraine prevention in Taiwan
Abstract Aim Migraine is a neurological disorder prevalent in Taiwan, affecting millions of individuals and imposing a substantial burden on both quality of life and societal productivity. Calcitonin gene-related peptide inhibitors, such as eptinezumab, represent a major advancement in migraine prev...
-д хадгалсан:
| Үндсэн зохиолчид: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
BMC
2025-12-01
|
| Цуврал: | Health Economics Review |
| Нөхцлүүд: | |
| Онлайн хандалт: | https://doi.org/10.1186/s13561-025-00711-x |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|